The Proof with Simon Hill

Cholesterol and dementia | Dr Kellyann Niotis, Md and Dr Thomas Dayspring, Md

171 snips
Sep 30, 2024
Guest
Kellyann Niotis
Guest
Thomas Dayspring
Dr. Kellyann Niotis, a preventive neurologist, and Dr. Thomas Dayspring, a lipidologist, dive into the intriguing connection between cholesterol and dementia. They highlight vital preventive strategies for brain health, discussing the role of LDL cholesterol, genetic factors like the ApoE4 allele, and the significance of early lifestyle changes. With insights into personalized health strategies, they explore how managing cholesterol levels can be an effective way to reduce the risk of cognitive decline. Don't miss their tips on omega-3 fatty acids and new therapeutic approaches!
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Preclinical Dementia

  • 55 million people globally have dementia, with another 50 million in a preclinical stage.
  • Preclinical individuals show brain changes but lack noticeable cognitive symptoms.
INSIGHT

MCI vs. Dementia

  • Mild cognitive impairment (MCI) differs from preclinical disease; MCI shows objective cognitive deficits.
  • Dementia stages involve functional decline and loss of independence in daily activities.
INSIGHT

Amyloid and Dementia

  • Amyloid buildup alone doesn't always cause dementia; some with amyloid never develop it.
  • Inflammation, cardiovascular issues, metabolic and hormonal health may drive amyloid and tau.
Get the Snipd Podcast app to discover more snips from this episode
Get the app